Skip to main content
logo
BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.38
+0.08 (0.86%)
At close: Aug 7, 2026, 4:00 PM EDT
9.42
+0.04 (0.43%)
After-hours: Aug 7, 2026, 7:51 PM EDT

BioCryst Pharmaceuticals Revenue by Segment

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Orladeyo
617.31M615.94M601.84M574.34M531.59M483.04M437.66M404.36M
Orladeyo Growth
16.13%27.51%37.51%42.04%42.24%39.43%34.26%32.21%
Other
323.31M269.77M273.00M25.47M25.92M20.45M13.05M8.22M
Other Growth
1,147.27%1,219.25%1,991.62%209.82%204.45%128.43%140.72%-29.82%

Revenue by Type

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Product
625.85M630.77M623.15M593.30M551.63M497.18M442.67M404.06M
Product Growth
13.46%26.87%40.77%46.83%47.78%43.78%36.33%29.50%
Collaborative and Other
314.77M254.95M251.69M6.52M5.88M6.30M8.04M8.52M
Collaborative and Other Growth
5,253.15%3,945.56%3,028.87%-23.43%-34.31%-34.31%19.77%53.86%

Revenue by Geography

Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
United States
594.83M576.97M548.78M509.03M470.58M426.15M385.96M358.41M
United States Growth
26.40%35.39%42.19%42.02%42.36%38.60%33.85%31.50%
Outside of US
22.48M38.98M53.06M65.32M61.00M56.88M51.70M45.94M
Outside of US Growth
-63.15%-31.48%2.63%42.17%41.37%45.98%37.39%38.00%